Erectile dysfunction, also called impotence, is the type of sexual dysfunction in which the penis fails to become, or stay erect during sexual activity. It is the most common sexual problem in men.

Through its connection to self-image and to problems in sexual relationships, erectile dysfunction can cause psychological harm.

Genital vibration therapy for sexual function and enhancement.

Vibration therapy, as provided by a genital vibrator, provides stimulation for the treatment of sexual dysfunction and/or sexual and relationship enhancement. (Genital vibration for sexual function and enhancement: a review of evidence. Jordan E. Rullo et al., 2018).

Vibrator therapy use for male genitalia primarily focuses on the penis as the target for vibratory stimulation. However, vibratory stimulation of other sexual organs including the testicles or scrotum, perineum, and anus has been described as well (Reece et al., 2010). Clinical experience suggests that males often prefer scrotal stimulation.

The penis contains a variety of superficial and deep nerve receptors that sense changes in pressure, temperature, stretch, and pain. A specific type of sensory mechanoreceptor known as a Pacinian corpuscle plays a prominent role in transduction of vibratory stimulation into afferent neural signals (Tajkarimi & Burnett, 2011). These signals are transmitted along individual nerve fibers, ultimately converging to form the dorsal nerve of the penis (DNP), which runs along the penile shaft. The DNP is a branch of the pudendal nerve (PN). Other branches from the ventral aspect of the penis, scrotum, and perineum also contribute to penile sensation (Everaert et al., 2010; Tajkarimi & Burnett, 2011).

Similar to the penis, the scrotum is innervated by distal branches of the PN, which carries sensory information proximally to the spinal cord (Tajkarimi & Burnett, 2011). Vibratory penile nerve stimulation is transmitted to the sacral spinal cord via the PN, where a complex network of inputs from the spinal cord, brainstem, and cerebral cortex takes place (Steers, 2000). Afferent signals from the PN are also transmitted to supraspinal centers involved in higher level processing including the medial preoptic area and paraventricular nuclei within the hypothalamus, thalamus, and even the cerebral cortex (Tajkarimi & Burnett, 2011).

Interestingly, several rat studies have shown that oxytocin-mediated neuronal signaling between pudendal afferents, the hypothalamus, and the sacral spinal cord contributes to penile erection (Argiolas, Melis, & Gessa, 1985). Afferents originating from the DNP excite oxytocin cells in the hypothalamic paraventricular nucleus of the rat (Tajkarimi & Burnett, 2011; Yanagimoto, Honda, Goto, & Negoro, 1996).

Efferent neuronal signals originating from the spinal cord result in predictable changes in sexual physiology (e.g. erection, ejaculation, orgasm) (Everaert et al., 2010; Steers, 2000). It is hypothesized that, by stimulating spinal reflexes, vibratory stimulation can be used to promote normal sexual function (Nelson, Ahmed, Valenzuela, Parker, & Mulhall, 2007).

For instance, the bulbocavernosus reflux results from stimulation of the DNP or other distal pudendal branches. Afferent signals traveling to the sacral spinal cord via the PN are integrated within Onuf’s nucleus, and subsequent efferent output from both autonomic and somatic neurons results in rhythmic contraction of the bulbospongiosus and ischiocavernosus muscles. This reflex contributes not only to penile rigidity and tumescence but also to ejaculatory function (Granata et al., 2013; Steers, 2000).

Clinically, this reflex is utilized to ascertain the integrity of the sacral spinal cord and is elicited in males by squeezing the glans penis and observing contraction of the anal musculature. While higher level processes including signals from the cerebral cortex play an important role in normal sexual function, reflexes such as the bulbocavernosus reflex help explain why digital (hand), oral, vaginal, and vibratory stimulation have a major role in eliciting erections as well.

Sexual arousal and genital vibration therapy

For men, erectile dysfunction (ED) is a novel target for vibratory stimulation (Rowland, den Ouden, & Slob, 1994; Sikka, Tajkarim, Burnett, & Hellstrom, 2016). Penile vibratory stimulation is thought to improve erectile function through stimulation of fibers in the cavernosal and PNs, resulting in release of nitric oxide which induces smooth muscle relaxation in the penile corporal cavernosa (Sonksen & Ohl, 2002).

In 2011, the FDA approved a vibratory stimulator known as the Viberect (Reflexonic; Chambersberg, Pennsylvania) for use in men with ED, as well as those with spinal cord injury, in order to induce ejaculation (Stein, Lin, & Wang, 2014). Subsequently, Segal, Tajkarimi, and Burnett (2013) demonstrated that four out of five patients achieved erection rigidity capable of sexual intercourse without buckling while using this device.

Vibratory stimulation has also been evaluated as an adjunct to recovery of erectile function after prostatectomy in men with prostate cancer (Fode & Sonksen, 2015). Fode and Sonkesen (2015) and Fode, Borre, Ohl, Lichtbach, and Sonksen (2014) randomized patients to daily penile vibratory stimulation after radical prostatectomy for a period of 6 weeks. The authors found a higher percentage of patients who had reached an IIEF-5 score of at least 18 in the vibratory stimulation group compared to controls (53% vs. 32%; P = 0.07).

Sexual desire and genital vibration therapy.

A study examining sexual function in male vibrator users also demonstrated higher sexual desire scores on the self-reported International Index of Erectile Function (IIEF) in those who used a vibrator in the last month than in those who used a vibrator more than a year previously. In addition, male vibrator users (within the last month and within the last year) had appreciably higher sexual desire scores than never users (Reece et al., 2009).

Penile vibratory stimulation is a commonly used means to produce ejaculation in men with and without spinal cord injury and in men with multiple sclerosis (Previnaire, Lecourt, Soler, & Denys, 2014; Sobrero et al., 1965; Sonksen & Ohl, 2002).

Importantly, this requires an intact ejaculatory reflex arc (Barazani, Stahl, Nagler, & Stember, 2012). As such, patients with spinal cord injuries below cord level T10 have a lower success rate with penile vibratory stimulation (Sonksen & Ohl, 2002). Vibratory amplitude also appears to play a role and has been shown to predict antegrade ejaculation success in patients with spinal cord injuries (Sonksen, Biering-Sorensen, & Kristensen, 1994).

Vibratory stimulation is a viable treatment option for premature ejaculation as well as delayed ejaculation in men without a history of spinal cord injury (Fode et al., 2014; Jern, 2014; Nelson et al., 2007; Segal et al., 2013).

Orgasm and genital vibration therapy

For men and women, genital vibratory stimulation has been found to be an effective treatment for anorgasmia (Laan et al., 2013; Leff & Israel, 1983; Marcus, 2011; Nelson et al., 2007; Segal et al., 2013). Genital vibratory stimulation is a common component of the directed masturbation (DM) treatment protocol, an empirically supported treatment for primary anorgasmia, supported by nine randomized controlled trials described by Graham (2014).

Overall sexual health and genital vibration therapy

Vibrator use in men was associated with higher scores in four of five domains of the IIEF (sexual desire, erectile function, orgasmic function, and intercourse satisfaction) (Reece et al., 2009).

Conclusion

Vibratory stimulation is a readily accessible and affordable treatment modality for both men and women. Evidence supports its use for ejaculatory dysfunction and anorgasmia, and there exists one FDA-approved vibration device specifically for the treatment of ED. Vibration is positively correlated with increased sexual desire and overall sexual function. It is a potential treatment for sexual arousal difficulties and pelvic floor dysfunction.

Furthermore, although more research is needed, the openness to sexual exploration and/or good sexual communication evidenced by vibrator use among couples may enhance sexual and relationship satisfaction. Genital vibration is a potential treatment for sexual dysfunction related to a wide variety of sexual health concerns in both women and men and a valuable tool for health care providers in the treatment of sexual function concerns.

Do you suffer from erectile dysfunction, anorgasmia, premature ejaculation or delayed ejaculation?

If you suffer from low sex drive, premature ejaculation, erectile dysfunction, or low libido, you should consider the Warrior Vibration Therapy Device. Get your sex life in 1st gear, Get and maintain an excellent healthy Erection and last up to 5 times longer in bed. Safe to use, even with high blood pressure and diabetes.

What’s the Benefits ?

You will have a lot of benefits when you get treatment for erectile dysfunction, anorgasmia, premature ejaculation or delayed ejaculation, not only sexual benefits but a real deepening of your relationship.

Stronger Erections – Stronger harder erection power

Stamina – up to 5 times more stamina and power

Premature Ejaculation – Cure premature ejaculation

Longer Lasting – Erections lasting up to 3 times longer

Orgasms – Much more intense orgasms

Light therapy as a treatment for sexual dysfunctions

Letizia Bossini, Claudia Caterini, Despoina Koukouna, Ilaria Casolaro, Monica Roggi, Silvia Di Volo, Francesco Fargnoli, Roberto Ponchietti, Jim Benbow, Andrea Fagiolini – 2013

Seasonal trends were demonstrated in reproduction and sexual activity. Through the secretion of melatonin the pineal gland plays an important role in the neuroendocrine control of sexual function and reproductive physiology.

We recruited 24 subjects with a diagnosis of hypoactive sexual desire disorder and/or primary sexual arousal disorder. The subjects were randomly assigned to either active light treatment (ALT) or placebo light treatment (L-PBO). Participants were assessed during the first evaluation and after 2 weeks of treatment, using the Structured Clinical Interview for Sexual Disorders DSM-IV (SCID-S) and a self-administered rating scale of the level of sexual satisfaction (1 to 10). Repeated ANOVA measures were performed to compare the two groups of patients. Post-hoc analysis was performed by Holm-Sidak test for repeated comparisons.

Results. At baseline the two groups were comparable. After 2 weeks the group treated with Light Therapy showed a significant improvement in sexual satisfaction, about 3 times higher than the group that received placebo, while no significant improvement was observed in the group L-PBO.

Effectiveness of low level laser therapy for treating male infertility

Sergey Vladimirovich Moskvin and Oleg Ivanovich Apolikhin – 2018

Despite the active debates and discussions on the topic of the presence/absence of “full-fledged” diagnostics, the case of idiopathic sperm quality disorders in more than half of the cases of male infertility is unquestionable. Consequently, in the first place clinicians should consider the non-specific treatment methods aimed at “general improvement” that trigger the mechanisms of sanogenesis, restoration of disturbed homeostasis and normal physiological regulation.

Previously, it was thought that laser therapy was only of an auxiliary nature and is prescribed in conjunction with drug therapy or at the final stage of traditional treatment, but further studies completely refute this view. Analysis of the scientific literature suggests that laser therapy should be used as much as possible in the complex treatment of men with infertility, since the effectiveness of the method is not just high, but often has no alternatives. For laser illumination, it is best to use exclusively pulsed LILI, red (635 nm) and infrared (904 nm) for local illumination, alternating with continuous LILI with a wavelength of 635 nm (red spectrum) and 365 nm (ultraviolet) for intravenous laser blood illumination.

It is necessary to use the available low level laser therapy methods as widely as possible: local, rectal, laser acupuncture, ILBI, on the projection of various organs, paravertebrally, etc., while setting all parameters of the laser (wavelength, mode of operation, frequency for pulsed lasers, power, density power determined by the method of exposure, exposure, localization), which are established by appropriate regulatory documents and clinical recommendations

Effects of Transcranial Photobiomodulation (t-PBM) with Near-Infrared Light on Sexual Dysfunction

Paolo Cassano, Christina Dording, Garrett Thomas, Simmie Foster, Albert Yeung, Mai Uchida, Michael R. Hamblin, Eric Bui, Maurizio Fava, David Mischoulon, and Dan V. Iosifescu – 2019

The nature or cause of the sexual dysfunction in our cohort is multifactorial; while the underlying depressive syndrome was common to all included patients, multiple other potential factors coexisted such as comorbid medical conditions and pharmacotherapies. Given that we had previously demonstrated an antidepressant effect for t-PBM in the same cohort, we attempted to untangle the effect of t-PBM on sexual dysfunction from its effect on depression. In the current study, the timing and the magnitude of the effect of t-PBM on sexual dysfunction were much faster and far greater than its effect on depression; this contradicts any speculation that sexual function improved because of the lessening of the depressive syndrome. On the contrary, t-PBM is likely to benefit sexual function independently from the outcome of depression.

If so, the intriguing question is “how does t-PBM work on sexual function?” Two rather different hypotheses about mechanisms can be considered: (i) the effect is mediated by direct neuromodulation of the central nervous system, more specifically of the targeted prefrontal cortex (i.e., enhanced EEG activity) and (ii) the effect is mediated by an increase in signaling molecules, such as neuronal nitric oxide (NO). Not only NO is increased by t-PBM with NIR but also neuronal, intra- or extra-cellular NO in the hypothalamus is postulated to be essential to onset of puberty and to fertility, and regulates GnRH and LH release.

Treatment at Light Care

A treatment session takes 45 minutes and consists of:

  • Transcranial photobiomodulation with our Brain Care helmet. This device has a wavelength of 810 nm.
  • Irradiation of the prostate at 850 nm.
  • Irradiation of the testes at 633 nm and 850 nm.

Additional at home self-treatment:

As part of this treatment you will receive a vibration therapy device that you can use in the privacy of your home at least twice per week.

Treatment schedule:

  • 2 x per week for 5 weeks.

Cost:

R7985 – This is the total price for 10 laser treatment sessions and the vibration therapy device

Inquiries and bookings:

063 409 8742 or info@lightcare.be